Published January 15, 2025 | Version v2

Supplementary Material and Date for Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomised Controlled Trials

  • 1. People's Hospital of Zhengzhou University
  • 2. Huazhong University of Science and Technology

Description

This dataset contains supplementary material and raw data from the Study of the Effects of SGLT2 Inhibitors (SGLT2i) on Cardiovascular Consequences in Type 1 Diabetes Mellitus (T1DM). Supplementary material includes tables and figures. The raw data are the original data for outcomes associated with the high-dose and placebo groups in the RCTs that met the study's inclusion requirements. The dataset is intended to provide additional evidence for the main publication and is organised for easy access.

Files

Files (2.0 MB)

Name Size Download all
md5:914e210a1e5b4cc568d39f4cf481aff4
85.5 kB Download
md5:fc48d73acf88453f3970faeca1fc841d
1.9 MB Download

Additional details

Identifiers

Related works

Is referenced by
Dataset: 10.1210/clinem/dgaf016 (DOI)
Is supplement to
Other: 10.1210/clinem/dgaf016 (DOI)

Dates

Accepted
2025-01-15

References

  • Songwei Wang, Yueqi Zhang, Abudunaibi Balati, Bing Li, Lei Dai, Dan Yu, Effect of Sodium-Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials, The Journal of Clinical Endocrinology & Metabolism, 2025;, dgaf016, https://doi.org/10.1210/clinem/dgaf016